-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UDQPAhW9ipbpp7NqLpiQQhwZJ/Midmp91ik38VlM4snfE8l+RLq/668rW5BOL7SF
 cfxRLK4I4abxgooJhOf8Jw==

<SEC-DOCUMENT>0001209499-03-000095.txt : 20030620
<SEC-HEADER>0001209499-03-000095.hdr.sgml : 20030620
<ACCEPTANCE-DATETIME>20030620111529
ACCESSION NUMBER:		0001209499-03-000095
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20030527
FILED AS OF DATE:		20030620

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RIBAPHARM INC
		CENTRAL INDEX KEY:			0001116613
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				954805655

	BUSINESS ADDRESS:	
		STREET 1:		3300 WYLAND AVENUE
		STREET 2:		C/O ICN PHARMACEUTICALS INC
		CITY:			COSTA MESA
		STATE:			CA
		ZIP:			92626
		BUSINESS PHONE:		7144276236

	MAIL ADDRESS:	
		STREET 1:		3300 WYLAND AVENUE
		STREET 2:		C/O ICN PHARMACEUTICALS INC
		CITY:			COSTA MESA
		STATE:			CA
		ZIP:			92626

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			DIMITRIADIS ANDRE C
		CENTRAL INDEX KEY:			0000938132

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31294
		FILM NUMBER:		03751173

	BUSINESS ADDRESS:	
		STREET 1:		9955 SE WASHINGTON
		STREET 2:		SUITE 201
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97216
		BUSINESS PHONE:		5032526233

	MAIL ADDRESS:	
		STREET 1:		9955 SE WASHINTON
		STREET 2:		SUITE 201
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97216
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgardoc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0101</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2003-05-27</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001116613</issuerCik>
        <issuerName>RIBAPHARM INC</issuerName>
        <issuerTradingSymbol>RNA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000938132</rptOwnerCik>
            <rptOwnerName>DIMITRIADIS ANDRE C</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>  </rptOwnerStreet1>
            <rptOwnerStreet2>  </rptOwnerStreet2>
            <rptOwnerCity>  </rptOwnerCity>
            <rptOwnerState>  </rptOwnerState>
            <rptOwnerZipCode>  </rptOwnerZipCode>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeSecurity>
        <securityTitle>
            <value>Non-Qualified Stock Option (right to buy)</value>
        </securityTitle>
        <conversionOrExercisePrice>
            <value>4.95</value>
        </conversionOrExercisePrice>
        <transactionDate>
            <value>2003-05-27</value>
        </transactionDate>
        <transactionCoding>
            <transactionFormType>4</transactionFormType>
            <transactionCode>A</transactionCode>
            <equitySwapInvolved>0</equitySwapInvolved>
        </transactionCoding>
        <transactionAmounts>
            <transactionShares>
                <value>15000</value>
            </transactionShares>
            <transactionValue>
                <value>0</value>
            </transactionValue>
            <transactionAcquiredDisposedCode>
                <value>A</value>
            </transactionAcquiredDisposedCode>
        </transactionAmounts>
        <exerciseDate>
            <value>2004-05-27</value>
                <footnoteId id="F1"/>
        </exerciseDate>
        <expirationDate>
            <value>2013-05-27</value>
        </expirationDate>
        <underlyingSecurity>
            <underlyingSecurityTitle>
                <value>Common Stock</value>
            </underlyingSecurityTitle>
            <underlyingSecurityShares>
                <value>15000</value>
            </underlyingSecurityShares>
        </underlyingSecurity>
        <postTransactionAmounts>
            <valueOwnedFollowingTransaction>
                <value>15000</value>
            </valueOwnedFollowingTransaction>
        </postTransactionAmounts>
        <ownershipNature>
            <directOrIndirectOwnership>
                <value>D</value>
            </directOrIndirectOwnership>
        </ownershipNature>
    </derivativeSecurity>

    <footnotes>
        <footnote id="F1">This option vests in four equal parts beginning one year following the date of grant and on each subsequent anniversary of the date of grant.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>By: Michelle May  For: Andre Dimitriadis</signatureName>
        <signatureDate>2003-06-19</signatureDate>
    </ownerSignature>

</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----